Tariff refunds are juicing corporate profits and GDP as more tailwinds converge to propel growth to a blistering 4.3% pace, top economist says ‘If your tariff was 0%, there’s no need to commit fraud’: The White House is sounding off on a $112 billion tariff-dodging scheme it made worse U.S. stocks fall after Iran says Strait of Hormuz will remain shut Trump is betting that the U.S. naval blockade choking Iran’s economy can achieve what bombs and missiles couldn’t as more oil sneaks out of the Gulf Gordan Chang – “China Is Broke – Rulers Are Desperate – Bad Things Are Going to Happen” American Airlines will stop upgrading elite flyers to business from coach on long domestic flights Does Africa still back Infantino as Fifa president? A billion SpaceX shares unlock Thursday. Wall Street isn’t worried: ‘You never bet against Elon.

John Oyler

John Oyler

John Oyler (#2078)

Global Rank #2078
Country Rank #696
Country United States

John Oyler is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 2 B
  • Biotech
  • United States
  • M
  • 58 Years

Snapshot

Quick Facts

Global Rank #2,078
Country Rank #696
Net Worth $2.0B
Previous Worth $2.0B
Worth Change +$0.0B
Country United States
Industry Biotech
Age 58 Years
Gender M
Worth As Of May 4, 2026
Last Refreshed 31 Jul 2026, 12:00 AM
Residence Reno, Nevada
World Billionaires List United States Billionaires Biotech

Profile Data

Personal Stats

Age 58
Source Of Wealth Biotech, Self Made
Residence Reno, Nevada
Citizenship United States
Marital Status Married
Education Bachelor of Arts/Science, Massachusetts Institute of Technology; Master of Business Administration, Stanford Graduate School of Business
Net Worth Change +$0.0B +0.0% from previous worth
Previous Net Worth $2.0B
Current Net Worth $2.0B

Worth as of May 4, 2026

About Me

John Oyler is the CEO, cofounder and chairman of global oncology company BeOne Medicines. He owns nearly 5% of the publicly traded company. BeOne Medicines, which was formerly called BeiGene, was founded in 2010 as a research and development firm. It went public on the Nasdaq in 2016 and listed in Hong Kong two years later. Before he cofounded BeOne, Oyler helped start and then sell two companies in the U.S. and China. He sold Telephia, a consumer telecom research firm he founded in 1997, to The Nielsen Co. for $449 million in 2007. Oyler's next success came with drug discovery outsourcing company BioDuro, which he founded in 2005 and sold to PPD Inc. for $77 million in 2010.

Insights

Did You Know?

BeOne has more than 40 drugs in its pipeline. Its blood cancer drug Brukinsa did more than $2 billion in U.S. sales in 2024.

Wealth Growth

Net Worth Growth Over Time

Tracking John Oyler's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $2.0B (May 4, 2026)

© Iconic Billionaires